• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALLERGAN (PRINGY) JUVÉDERM VOLUMA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALLERGAN (PRINGY) JUVÉDERM VOLUMA WITH LIDOCAINE; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Catalog Number 96637JR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Abscess (1690)
Event Date 02/01/2022
Event Type  Injury  
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.The event of abscess is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Clarification: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
 
Event Description
Healthcare professional (hcp) reported patient was injected with 3 syringes of juvéderm® voluma¿ with lidocaine and experienced early inflammation with pus drainage.Patient was prescribed antibiotics.Symptoms improved, but the induration persisted and the inflammation recurred.Patient was prescribed corticoids and varidasa.One week later, patient was prescribed antibiotics again.Patient developed a zone with apparent purulent collection that hasn't been drained.This is the same event and the same patient reported under mdr id# 3005113652-2022-00239 (allergan complaint #(b)(4)).This mdr is being submitted for the suspect product, juvéderm® voluma¿ with lidocaine with lot number vb20b10414.
 
Manufacturer Narrative
Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been completed.No deviations or non-conformances noted.
 
Event Description
Healthcare professional (hcp) reported patient was injected with 3 syringes of juvéderm® voluma¿ with lidocaine and experienced early inflammation with pus drainage.Patient was prescribed antibiotics.Symptoms improved, but the induration persisted and the inflammation recurred.Patient was prescribed corticoids and varidasa.One week later, patient was prescribed antibiotics again.Patient developed a zone with apparent purulent collection that hasn't been drained.This is the same event and the same patient reported under mdr id# 3005113652-2022-00239 (allergan complaint #pr (b)(4).This mdr is being submitted for the suspect product, juvéderm® voluma¿ with lidocaine with lot number vb20b10414.
 
Event Description
Additional information noted a depression area where the abscess was but was corrected using hyaluronic acid.The event resolved approximately three months and a half after onset.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JUVÉDERM VOLUMA WITH LIDOCAINE
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer (Section G)
ALLERGAN (PRINGY)
route de promery
zone artisanale de pre-mairy
pringy
Manufacturer Contact
chris sprague
12331-a riata trace parkway
building 3
austin, TX 78727
8479375615
MDR Report Key14213047
MDR Text Key290117442
Report Number3005113652-2022-00238
Device Sequence Number1
Product Code LMH
UDI-Device Identifier05016007208092
UDI-Public5016007208092
Combination Product (y/n)Y
Reporter Country CodeSP
PMA/PMN Number
P110033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 07/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/31/2023
Device Catalogue Number96637JR
Device Lot NumberVB20B10414
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/13/2022
Initial Date FDA Received04/26/2022
Supplement Dates Manufacturer Received06/01/2022
07/01/2022
Supplement Dates FDA Received06/09/2022
07/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/14/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
Patient SexFemale
-
-